InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the complete record of transactions filed by Frohlich Tom, Deputy Chief Executive. Officer active across 1 company, notably Chinook Therapeutics, INC.. In total, 11 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €609k. Activity tracked since 24 September 2021. The latest transaction was disclosed on 10 November 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
6,801 sharesCommon StockSEC:0001209191-22-009560:0
6,230 shares@ US$15.4813.1% of flowCommon StockSEC:0001209191-21-064364:0
6,230 shares@ US$15.4826.2% of flowCommon StockSEC:0001209191-21-064364
15,000 shares@ US$0.421.7% of flowCommon StockSEC:0001209191-21-063790
15,000 shares@ US$0.420.9% of flowCommon StockSEC:0001209191-21-063790:0
13,580 sharesCommon StockSEC:0001209191-21-060114:0
13,580 sharesCommon StockSEC:0001209191-21-060114
20,000 shares@ US$0.422.3% of flowCommon StockSEC:0001209191-21-057937
20,000 shares@ US$0.421.1% of flowCommon StockSEC:0001209191-21-057937:0
20,000 shares@ US$13.0069.8% of flowCommon StockSEC:0001209191-21-057713
20,000 shares@ US$13.0034.9% of flowCommon StockSEC:0001209191-21-057713:0
11 of 11 declarations
About Frohlich Tom
Tom Frohlich is the Chief Operating Officer at Chinook Therapeutics, Inc. He oversees the company's operations, ensuring efficiency and profitability. With extensive experience in the industry, he plays a key role in optimizing business performance and enhancing the customer experience.
